Cantor Fitzgerald Says Buy Avita Medical Ltd. (RCEL) on Weakness Following Q1 Results

Go back to Cantor Fitzgerald Says Buy Avita Medical Ltd. (RCEL) on Weakness Following Q1 Results

AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 21c ; Offers Guidance

May 8, 2025 4:48 PM EDT

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.53), $0.21 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $20.75 million.

GUIDANCE:

AVITA Medical, Inc. sees FY2025 revenue of $100-106 million, versus the... More